In Vitro Assessment of the Expression and T Cell Immunogenicity of the Tumor-Associated Antigens BORIS, MUC1, hTERT, MAGE-A3 and Sp17 in Uterine Cancer
Background: While immunotherapy moved to the forefront of treatment of various cancers, it remains underexplored for uterine cancer. This might be due to the small patient population with advanced endometrial carcinoma and uterine sarcoma. Data about immunotherapeutic targets are scarce in endometri...
Main Authors: | Anke Vanderstraeten, Sandra Tuyaerts, Tina Everaert, Rieta Van Bree, Godelieve Verbist, Cathérine Luyten, Frederic Amant |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2016-09-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/17/9/1525 |
Similar Items
-
A Phase 2 Study to Assess the Immunomodulatory Capacity of a Lecithin-based Delivery System of Curcumin in Endometrial Cancer
by: Sandra Tuyaerts, et al.
Published: (2019-01-01) -
Endometrial Stromal Sarcomas: A Revision of Their Potential as Targets for Immunotherapy
by: Sandra Tuyaerts, et al.
Published: (2018-08-01) -
Bacterial Immunogenicity Prediction by Machine Learning Methods
by: Ivan Dimitrov, et al.
Published: (2020-11-01) -
Immunogenicity Evaluation of Recombinant Edible Vaccine Candidate Containing HER2-MUC1 against Breast Cancer
by: Mahdieh Mehrab Mohseni, et al.
Published: (2019-10-01) -
Commentary: Immunogenic Cell Death and Immunotherapy of Multiple Myeloma
by: Ken Maes, et al.
Published: (2019-07-01)